Xenon Pharmaceuticals (XENE) Reiterated at Overweight by JPMorgan
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- Nasdaq rallies as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| (NASDAQ: XENE) | Delayed: 38.53 +0.91 (2.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $37.62 | 52 Week High | $9.75 | |||
| Open | $38.04 | 52 Week Low | $5.65 | |||
| Day High | $39.00 | P/E | N/A | |||
| Day Low | $37.78 | EPS | $0.00 | |||
| Volume | 712,827 | |||||
